ABCLVSPRME• 3 Months (Normalized)
ABCL vs PRME (AbCellera Biologics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Jun, 17 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABCL Performance $11.41
+109.74%
AbCellera Biologics Inc.
Normalized Baseline0.00%
PRME Performance $3.14
-0.63%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin ABCL LEADS
+110.37%
ABCL outperforming by 110.37%
ABCLPRME
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABCL PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ABCL Price | ABCL Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $11.41 | +109.74% | $3.14 | -0.63% | +110.37% |
| Sep 14, 2026 | $11.17 | +105.33% | $3.18 | +0.63% | +104.70% |
| Sep 11, 2026 | $10.89 | +100.18% | $3.13 | -0.95% | +101.13% |
| Sep 10, 2026 | $10.46 | +92.28% | $3.35 | +6.01% | +86.27% |
| Sep 09, 2026 | $11.05 | +103.13% | $3.47 | +9.81% | +93.32% |
| Sep 08, 2026 | $11.44 | +110.29% | $3.56 | +12.66% | +97.63% |
| Sep 04, 2026 | $11.43 | +110.11% | $3.70 | +17.09% | +93.02% |
| Sep 03, 2026 | $11.57 | +112.68% | $3.71 | +17.41% | +95.27% |
| Sep 02, 2026 | $11.36 | +108.82% | $3.67 | +16.14% | +92.68% |
| Sep 01, 2026 | $11.28 | +107.35% | $3.57 | +12.97% | +94.38% |
| Aug 31, 2026 | $11.48 | +111.03% | $3.59 | +13.61% | +97.42% |
| Aug 28, 2026 | $11.35 | +108.64% | $3.61 | +14.24% | +94.40% |
| Aug 27, 2026 | $12.40 | +127.94% | $3.64 | +15.19% | +112.75% |
| Aug 26, 2026 | $12.24 | +125.00% | $3.58 | +13.29% | +111.71% |
| Aug 25, 2026 | $12.50 | +129.78% | $3.71 | +17.41% | +112.37% |
Page 1 of 5